eFFECTOR Therapeutics (FRA:LWK) Accumulated Depreciation : €-0.32 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is eFFECTOR Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

eFFECTOR Therapeutics's quarterly accumulated depreciation increased from Sep. 2023 (€-0.28 Mil) to Dec. 2023 (€-0.30 Mil) and increased from Dec. 2023 (€-0.30 Mil) to Mar. 2024 (€-0.32 Mil).

eFFECTOR Therapeutics's annual accumulated depreciation increased from Dec. 2021 (€-0.18 Mil) to Dec. 2022 (€-0.20 Mil) and increased from Dec. 2022 (€-0.20 Mil) to Dec. 2023 (€-0.30 Mil).

eFFECTOR Therapeutics Accumulated Depreciation Historical Data

The historical data trend for eFFECTOR Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

eFFECTOR Therapeutics Accumulated Depreciation Chart

eFFECTOR Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

-0.16

-0.18

-0.20

-0.30

eFFECTOR Therapeutics Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial										-0.23	-0.25	-0.28	-0.30	-0.32

eFFECTOR Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

eFFECTOR Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of eFFECTOR Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

eFFECTOR Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

EFTR:USA

Address

142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075

Website

https://www.effector.com

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

eFFECTOR Therapeutics Headlines

No Headlines